BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20013178)

  • 1. Assessment of antioxidant activity of eugenol in vitro and in vivo.
    Nagababu E; Rifkind JM; Boindala S; Nakka L
    Methods Mol Biol; 2010; 610():165-80. PubMed ID: 20013178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent antioxidant and genoprotective effects of boeravinone G, a rotenoid isolated from Boerhaavia diffusa.
    Aviello G; Canadanovic-Brunet JM; Milic N; Capasso R; Fattorusso E; Taglialatela-Scafati O; Fasolino I; Izzo AA; Borrelli F
    PLoS One; 2011; 6(5):e19628. PubMed ID: 21625488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant Capacity of Eugenol and Its Effect on Intestinal Flora Under in Vitro Simulated Conditions.
    Dai J
    Stud Health Technol Inform; 2023 Nov; 308():715-722. PubMed ID: 38007803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant Activity and Skin Sensitization of Eugenol and Isoeugenol: Two Sides of the Same Coin?
    Port-Lougarre Y; Gourlaouen C; Vileno B; Giménez-Arnau E
    Chem Res Toxicol; 2023 Nov; 36(11):1804-1813. PubMed ID: 37922503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells.
    Jaganathan SK; Supriyanto E
    Molecules; 2012 May; 17(6):6290-304. PubMed ID: 22634840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the In Vitro Potential of Natural Extracts to Protect Lipids from Oxidative Damage.
    Félix R; Valentão P; Andrade PB; Félix C; Novais SC; Lemos MFL
    Antioxidants (Basel); 2020 Mar; 9(3):. PubMed ID: 32168810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases.
    Mori R; Abe M; Saimoto Y; Shinto S; Jodai S; Tomomatsu M; Tazoe K; Ishida M; Enoki M; Kato N; Yamashita T; Itabashi Y; Nakanishi I; Ohkubo K; Kaidzu S; Tanito M; Matsuoka Y; Morimoto K; Yamada KI
    Redox Biol; 2024 May; 73():103186. PubMed ID: 38744193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant activity of eugenol: a structure-activity relationship study.
    Gülçin İ
    J Med Food; 2011 Sep; 14(9):975-85. PubMed ID: 21554120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eugenol: a natural compound with versatile pharmacological actions.
    Pramod K; Ansari SH; Ali J
    Nat Prod Commun; 2010 Dec; 5(12):1999-2006. PubMed ID: 21299140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint.
    Marchese A; Barbieri R; Coppo E; Orhan IE; Daglia M; Nabavi SF; Izadi M; Abdollahi M; Nabavi SM; Ajami M
    Crit Rev Microbiol; 2017 Nov; 43(6):668-689. PubMed ID: 28346030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological Activities of Red Pepper (Capsicum annuum) and Its Pungent Principle Capsaicin: A Review.
    Srinivasan K
    Crit Rev Food Sci Nutr; 2016 Jul; 56(9):1488-500. PubMed ID: 25675368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of anti-inflammatory activities of α-D-glucosylated eugenol.
    Zhang P; Zhang E; Xiao M; Chen C; Xu W
    Arch Pharm Res; 2013 Jan; 36(1):109-15. PubMed ID: 23325490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin.
    Dwivedi V; Shrivastava R; Hussain S; Ganguly C; Bharadwaj M
    Asian Pac J Cancer Prev; 2011; 12(8):1989-93. PubMed ID: 22292639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compounds from Syzygium aromaticum possessing growth inhibitory activity against oral pathogens.
    Cai L; Wu CD
    J Nat Prod; 1996 Oct; 59(10):987-90. PubMed ID: 8904847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroprotective activity of essential oil of the Syzygium aromaticum and its major component eugenol in different animal models.
    Santin JR; Lemos M; Klein-Júnior LC; Machado ID; Costa P; de Oliveira AP; Tilia C; de Souza JP; de Sousa JP; Bastos JK; de Andrade SF
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):149-58. PubMed ID: 21140134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clove and Its Active Compound Attenuate Free Fatty Acid-Mediated Insulin Resistance in Skeletal Muscle Cells and in Mice.
    Ghaffar S; Afridi SK; Aftab MF; Murtaza M; Hafizur RM; Sara S; Begum S; Waraich RS
    J Med Food; 2017 Apr; 20(4):335-344. PubMed ID: 28338397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of clove oil and eugenol microemulsions on fatty liver and dyslipidemia as components of metabolic syndrome.
    Al-Okbi SY; Mohamed DA; Hamed TE; Edris AE
    J Med Food; 2014 Jul; 17(7):764-71. PubMed ID: 24611461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic effects of clove (Syzygium aromaticum flower buds) on genetically diabetic KK-Ay mice and identification of the active ingredients.
    Kuroda M; Mimaki Y; Ohtomo T; Yamada J; Nishiyama T; Mae T; Kishida H; Kawada T
    J Nat Med; 2012 Apr; 66(2):394-9. PubMed ID: 21987283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clove (Syzygium aromaticum Linn) extract rich in eugenol and eugenol derivatives shows bone-preserving efficacy.
    Karmakar S; Choudhury M; Das AS; Maiti A; Majumdar S; Mitra C
    Nat Prod Res; 2012; 26(6):500-9. PubMed ID: 21711176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term dietary administration of eugenol in humans.
    Rompelberg CJ; Vogels JT; de Vogel N; Bruijntjes-Rozier GC; Stenhuis WH; Bogaards JJ; Verhagen H
    Hum Exp Toxicol; 1996 Feb; 15(2):129-35. PubMed ID: 8645503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.